Lung Biopsy in ARDS: Is It Worth the Risk?

DSpace/Manakin Repository

Lung Biopsy in ARDS: Is It Worth the Risk?

Citable link to this page

. . . . . .

Title: Lung Biopsy in ARDS: Is It Worth the Risk?
Author: Malhotra, Atul; Patel, Sanjay R

Note: Order does not necessarily reflect citation order of authors.

Citation: Malhotra, Atul, and Sanjay Patel. 2006. Lung biopsy in ARDS: is it worth the risk?. Critical Care 10(4): 160.
Full Text & Related Files:
Abstract: Progress in the treatment of acute respiratory distress syndrome (ARDS) has been slow, perhaps in part due to the heterogeneity in the biology underlying this syndrome. Open lung biopsy is a feasible approach to define various subcategories of underlying histology. In experienced hands, with careful selection of patients and close attention to details of critical care management, including mechanical ventilator settings, the procedure is safe even in patients with severe disease. However, further work is needed to define which patients, if any, experience a beneficial effect on outcome from this procedure. More research is needed on assessing efficacy of potential therapies within histologically defined subgroups. In the future, various biomarkers may be available to non-invasively classify ARDS patients from the standpoint of responsiveness to various therapies, such as gluco-corticoids.
Published Version: doi:10.1186/cc5001
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750997/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4661593

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters